PCVX
Vaxcyte Inc
NASDAQ: PCVX · HEALTHCARE · BIOTECHNOLOGY
$57.32
-2.40% today
Updated 2026-04-29
Market cap
$8.28B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-5.63
Dividend yield
—
52W range
$28 – $65
Volume
1.3M
Vaxcyte Inc (PCVX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-25.60%
ROA
-17.70%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2017 | — | $-17.24M | — | — | — |
| 2018 | $0.00 | $-29.48M | — | — | — |
| 2019 | $0.00 | $-50.27M | — | — | — |
| 2020 | $0.00 | $-89.22M | — | — | — |
| 2021 | $0.00 | $-100.08M | — | — | — |
| 2022 | $0.00 | $-223.49M | — | — | — |
| 2023 | $0.00 | $-402.27M | — | — | — |
| 2024 | $0.00 | $-463.93M | — | — | — |
| 2025 | $0.00 | $-766.63M | — | — | — |